Prognostic impact of HER2-low expression in hormone receptor positive early breast cancer

BACKGROUND: Recent data suggest that human epidermal growth factor receptor 2 (HER2)-low breast cancer may represent a distinct entity. We aimed to compare disease characteristics and outcomes between HER2-low and HER2-0 in estrogen receptor (ER) positive, early-stage breast cancer. METHODS: A singl...

Descripción completa

Detalles Bibliográficos
Autores principales: Mutai, Raz, Barkan, Tamar, Moore, Assaf, Sarfaty, Michal, Shochat, Tzippy, Yerushalmi, Rinat, Stemmer, Salomon M., Goldvaser, Hadar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414540/
https://www.ncbi.nlm.nih.gov/pubmed/34481367
http://dx.doi.org/10.1016/j.breast.2021.08.016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414540/
https://www.ncbi.nlm.nih.gov/pubmed/34481367
http://dx.doi.org/10.1016/j.breast.2021.08.016

Ejemplares similares